Veradermics, Inc (MANE)
↓ Download CSV| Metric (FY) | 2025 | 2024 | 2023 |
|---|---|---|---|
| Operating Income | -$72.35M | -$26.78M | — |
| Net Income | -$70.00M | -$26.49M | — |
| EPS (Diluted) | $-111.91 | $-37.05 | — |
| Total Assets | $152.62M | $55.53M | — |
| Total Liabilities | $9.16M | $4.72M | — |
| Shareholders' Equity | -$121.01M | -$48.48M | -$22.24M |
| Cash & Equivalents | $21.77M | $53.08M | — |
| Operating Cash Flow | -$71.60M | -$23.69M | — |
| Capital Expenditures | $24.0K | $0 | — |
| Shares Outstanding | 749.8K | 736.9K | — |